论文部分内容阅读
目的 探讨中、晚期原发性肝癌介入治疗的方法及其对二期手术切除的价值。方法 对 14 0例不能手术切除的中、晚期原发性肝癌 ,经不同介入方法治疗。结果 2 0例获得二期切除 (二期切除率为 14 .3 % )。综合治疗组 (B组 )二期切除率和 5年生存率分别为 2 4.1% (14 / 5 8)和 47.1% ,高于单方法组 (A组 )的 7.3 % (6/ 82 )和 0 ,两组比较差异有显著性 (P均 <0 .0 1)。二期切除与非二期切除患者的 1,3 ,5年生存率分别为 95 .0 % ,63 .5 % ,3 2 .9%及 5 8.3 % ,17.6% ,5 .5 %。结论 介入方法治疗中、晚期原发性肝癌可获得二期手术切除。综合介入治疗方法的二期切除和远期生存率高于单一的介入治疗方法
Objective To investigate the interventional treatment of primary liver cancer in middle and late stage and its value for the second-stage surgical resection. Methods A total of 140 patients with unresectable primary and advanced primary liver cancer were treated with different intervention methods. Results Twenty patients received secondary resection (secondary resection rate was 14.3%). The secondary resection rate and 5-year survival rate of the comprehensive treatment group (B group) were 2 4.1% (14 / 58) and 47.1%, respectively, which was higher than the 7.3% (6 / 82) and 0 of the single-treatment group (group A). The difference between the two groups was significant (P < 0.01). The 1-, 3- and 5-year survival rates of patients with secondary and non-secondary resection were 95.0%, 63.5%, 32%, 58.3%, 17.6%, and 5.5%, respectively. Conclusion Interventional methods for the treatment of middle and late primary liver cancer can be achieved by two-stage surgical resection. Two-stage resection and long-term survival rate of comprehensive interventional treatment is higher than single interventional treatment